ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$21.83
-0.46 (-2.06%)
Performance
1D
—
1W
—
1M
—
3M
-24.65%
6M
+24.25%
1Y
+27.59%
YTD
-24.72%
Open$22.09
Previous Close$22.29
Day High$22.25
Day Low$21.57
52W High$31.77
52W Low$11.86
Volume—
Avg Volume1.19M
Market Cap2.84B
P/E Ratio—
EPS$-0.13
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.64
Below
SMA 200
$20.38
Above
RSI (14)
67.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+292.9% upside
Current
$21.83
$21.83
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 378.17M | 947.52M | 972.47M |
| Net Income | -16,235,913 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -11,847,482 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |